BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) is the most common form of inherited kidney disease that results in renal failure. ADPKD is a systemic disorder with cysts and connective tissue abnormalities involving many organs. ADPKD caused by mutations in PKD1 gene is significantly more severe than the cases caused by PKD2 gene mutations. The large intra-familial variability of ADPKD highlights a role for genetic background. CASE PRESENTATION: Here we report a case of ADPKD family initially appearing unlinked to the PKD1 or PKD2 loci and the influence of mosaicism and hypomorphic allele on the variability of the clinical course of the disease. A grandmother with the PKD1 gene mutation in mosaicism (p.Val1105ArgfsX4) and with mild clinical course of ADPKD (end stage renal failure at the age of 77) seemed to have ADPKD because of PKD2 gene mutation. On the other hand, her grandson had a severe clinical course (end stage renal disease at the age of 45) in spite of the early treatment of mild hypertension. There was found by mutational analysis of PKD genes that the severe clinical course was caused by PKD1 gene frameshifting mutation inherited from his father and mildly affected grandmother in combination with inherited hypomorphic PKD1 allele with described missense mutation (p.Thr2250Met) from his clinically healthy mother. The sister with two cysts and with PKD1 hypomorphic allele became the kidney donor to her severely affected brother. CONCLUSION: We present the first case of ADPKD with the influence of mosaicism and hypomorphic allele of the PKD1 gene on clinical course of ADPKD in one family. Moreover, this report illustrates the role of molecular genetic testing in assessing young related kidney donors for patients with ADPKD.

Institute of Biology and Medical Genetics of the 1st Faculty of Medicine and General Teaching Hospital Charles University Albertov 4 Prague 2 128 00 Czech Republic

See more in PubMed

Hataboer N, van Dijk MA, Bogdanova N. Comparison of phenotype of polycystic kidney disease types 1 and 2. Lancet. 1999;353:103–107. doi: 10.1016/S0140-6736(98)03495-3. PubMed DOI

Harris PC, Bae KT, Rossetti S. Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2006;17:3013–3019. doi: 10.1681/ASN.2006080835. PubMed DOI

Rossetti S, Burton S, Strmecki L. The position of the polycystic kidney disease 1 (PKD1) gene mutation correlates with the severity of renal disease. J Am Soc Nephrol. 2002;13:1230–1237. doi: 10.1097/01.ASN.0000013300.11876.37. PubMed DOI

Rossetti S, Kubly VJ, Consugar MB. Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease. Kidney Int. 2009;75(8):848–855. doi: 10.1038/ki.2008.686. PubMed DOI PMC

Vujic M, Heyer CM, Ars A. Incompletely penetrant PKD1 alleles mimic the renal manifestations of ARPKD. J Am Soc Nephrol. 2010;21:1097–1102. doi: 10.1681/ASN.2009101070. PubMed DOI PMC

Consugar MB, Wong WC, Lundquist PA. Characterization of large rearrangements in autosomal dominant polycystic kidney disease and the PKD1/TSC2 contiguous gene syndrome. Kidney Int. 2008;74:1468–1479. doi: 10.1038/ki.2008.485. PubMed DOI PMC

Connor A, Lunt PW, Dolling C. Mosaicism in autosomal dominant polycystic kidney disease revealed by genetic testing to enable living related renal transplantation. Am J Transplant. 2008;8:232–237. PubMed

Miler SA, Dykes DD, Polesky MF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl AcidRes. 1988;16:1215. doi: 10.1093/nar/16.3.1215. PubMed DOI PMC

Watnick TJ, Piontek KB, Cordal TM, Weber H, Gandolph MA, Qian F, Lens XM, Neumann HPH, Germino GG. An unusual pattern of mutation in the duplicated portion of PKD1 is revealed by use of a novel strategy for mutation detection. Hum Mol Genet. 1997;6:1473–1481. doi: 10.1093/hmg/6.9.1473. PubMed DOI

Phakdeekitcharoen B, Watnick TJ, Germino GG. Mutation analysis of the entire replicated portion of PKD1 using genomic DNA samples. J Am Soc Nephrol. 2001;12(5):955–963. PubMed

Chaateigner-Boutin AL, Small I. Rapid high-throughput method for the detection and quantification of RNA editing based on high-resolution melting of amplicons. Nucleic Acids Res. 2007;35:e114. doi: 10.1093/nar/gkm640. PubMed DOI PMC

Barua M, Cil O, Paterson AD. Family history of renal disease severity predicts the mutated gene in ADPKD. J Am Soc Nephrol. 2009;20(8):1833–1838. doi: 10.1681/ASN.2009020162. PubMed DOI PMC

Reed B, McFann K, Kimberling WJ. Presence of de novo mutations in autosomal dominant polycystic kidney disease patiens without family history. Am J Kidney Dis. 2008;52:1042–1050. doi: 10.1053/j.ajkd.2008.05.015. PubMed DOI PMC

Rossetti S, Consugar MB, Chapman AB. Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2007;18:2143–2160. doi: 10.1681/ASN.2006121387. PubMed DOI

Perrichot R, Mercier B, Quere I. Novel mutations in the duplicated region of PKD1 gene. Eur J Hum Genet. 2000;8(5):353–359. doi: 10.1038/sj.ejhg.5200459. PubMed DOI

Kleffmann J, Frank V, Ferbert A, Bergmann C. Dosage-sensitive network in polycystic kidney and liver disease: Multiple mutations cause severe hepatic and neurological complications. J Hepatol. 2012;57:467–468. doi: 10.1016/j.jhep.2012.01.025. PubMed DOI

Bilineal inheritance of pathogenic PKD1 and PKD2 variants in a Czech family with autosomal dominant polycystic kidney disease - a case report

Novel mutations of PKD genes in the Czech population with autosomal dominant polycystic kidney disease